Cargando…

培美曲塞在晚期非小细胞肺癌二线及以上治疗中的疗效分析

BACKGROUND AND OBJECTIVE: Pemetrexed is a standard second-line therapy in advanced non-small cell lung cancer (NSCLC). Currently, cytotoxic treatments beyond second-line therapy are not available. This study evaluated the efficacy and safety of pemetrexed as a salvage regimen in heavily pretreated p...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999869/
https://www.ncbi.nlm.nih.gov/pubmed/22429582
http://dx.doi.org/10.3779/j.issn.1009-3419.2012.03.08